STOCK TITAN

Palisade Bio: RA Capital reports 9.99% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Palisade Bio, Inc. (PALI) was the issuer in an amended ownership disclosure in which RA Capital Management, L.P., RA Capital Healthcare Fund, L.P., and the fund’s managers Peter Kolchinsky and Rajeev Shah each listed the same 20,884,964-share beneficial-ownership amount as of September 30, 2026. The reported position carried shared voting and dispositive power; sole voting and dispositive power were zero. Item 4 states 9.99%, while the cover pages display 9.9%, rounded down because of EDGAR field limits.

The Fund directly held 7,124,116 common shares and pre-funded warrants exercisable for up to 16,614,285 shares. A Beneficial Ownership Blocker precludes exercise if the Fund and attribution parties would own more than 9.99%; the report says a portion could not then be exercised if it would result in ownership above 20,884,964 shares. The Fund delegated sole voting and dispositive power to RA Capital and disclaimed beneficial ownership for Section 13(d) purposes. RA Capital, Kolchinsky and Shah also disclaimed beneficial ownership except for determining their Section 13(d) obligations.

Reported beneficial ownership 20,884,964 shares Same amount listed by each reporting person as of September 30, 2026; shared voting and dispositive power.
Ownership percentage 9.99% Percentage stated in Item 4 for September 30, 2026.
Cover-page ownership percentage 9.9% Rounded down due to EDGAR filing-system field limitations.
Common shares directly held by the Fund 7,124,116 shares Direct holdings described in Item 4.
Shares underlying pre-funded warrants Up to 16,614,285 shares Warrants directly held by the Fund, subject to the Beneficial Ownership Blocker.
Issuer shares outstanding 195,297,857 shares As of August 11, 2026, as reported in the issuer’s Quarterly Report on Form 10-Q.
Pre-Funded Warrants financial
"pre-funded warrants ("Pre-Funded Warrants") exercisable for up to"
Pre-funded warrants are financial instruments that give investors the right to purchase a company's stock at a set price, but with most or all of the purchase price paid upfront. They function like a coupon or gift card for stock, allowing investors to buy shares later at a fixed price, which can be beneficial if they want to avoid future price increases. This makes them important for investors seeking flexibility and certainty in their investment plans.
Beneficial Ownership Blocker regulatory
"The Pre-Funded Warrants contain a provision (the "Beneficial Ownership Blocker")"
A beneficial ownership blocker is a legal or structural device that prevents a shareholder from being treated as the ultimate owner of enough shares to trigger control, reporting, or voting thresholds. Think of it like a speed bump that stops an investor from reaching a stake size that would force corporate disclosure or change control rights. Investors care because it affects who controls the company, how shares vote, regulatory filings, takeover risk and therefore potential value or liquidity of their holdings.
beneficial ownership regulatory
"for purposes of Section 13(d) of the Act"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many PALI shares did the reporting persons report owning?

Each of the four reporting persons listed the same 20,884,964-share beneficial-ownership amount as of September 30, 2026. The amount was reported with shared voting and dispositive power; sole voting and dispositive power were zero.

How many PALI shares can the pre-funded warrants cover, and what limits exercise?

The Fund directly held pre-funded warrants exercisable for up to 16,614,285 shares. The Beneficial Ownership Blocker precludes exercise if the Fund, together with affiliates and other attribution parties, would own more than 9.99% of common stock outstanding.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





696389402

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



RA Capital Management, L.P.
Signature:/s/ Peter Kolchinsky
Name/Title:By Peter Kolchinsky, Authorized Signatory
Date:11/16/2026
Peter Kolchinsky
Signature:/s/ Peter Kolchinsky
Name/Title:Peter Kolchinsky
Date:11/16/2026
Rajeev Shah
Signature:/s/ Rajeev Shah
Name/Title:Rajeev Shah
Date:11/16/2026
RA Capital Healthcare Fund, L.P.
Signature:/s/ Peter Kolchinsky
Name/Title:By RA Capital Healthcare Fund GP, LLC, its General Partner, By Peter Kolchinsky, Manager
Date:11/16/2026
Exhibit Information

Exhibit 99.1 Joint Filing Agreement (incorporated by reference to Exhibit 99.1 to the Reporting Persons' Schedule 13G filed with the SEC on October 9, 2025)

Keep reading